PD-1 Blockade in Anaplastic Thyroid Carcinoma
-
Capdevila Castillón, Jaume (Vall d'Hebron Institut d'Oncologia)
;
Wirth, Lori J. (Harvard Medical School) ;
Ernst, Thomas (Universitätsklinikum Jena) ;
Ponce Aix, Santiago (Hospital Universitario 12 de Octubre (Madrid)) ;
Lin, Chia-Chi (National Taiwan University Hospital (Taipei, Taiwan)) ;
Ramlau, Rodryg (Poznań University of Medical Sciences) ;
Butler, Marcus O. (Princess Margaret Cancer Centre) ;
Delord, Jean-Pierre (IUCT Oncopole) ;
Gelderblom, Hans J (Leiden University Medical Center) ;
Ascierto, Paolo A. (Istituto Nazionale Tumori IRCCS Fondazione G. Pascale) ;
Fasolo, Angelica (San Raffaele Hospital) ;
Führer, Dagmar (University Hospital Essen (Alemanya)) ;
Hütter-Krönke, Marie Luise (University Hospital of Ulm (Alemanya)) ;
Forde, Patrick M. (Sidney Kimmel Comprehensive Cancer Center) ;
Wrona, Anna (Uniwersyteckie Centrum Kliniczne) ;
Santoro, Armando (IRCCS Humanitas University) ;
Sadow, Peter M. (Harvard Medical School) ;
Szpakowski, Sebastian (Novartis Institutes for BioMedical Research) ;
Wu, Hongqian (Novartis Pharmaceuticals) ;
Bostel, Geraldine (Novartis Institutes for BioMedical Research) ;
Faris, Jason (Novartis Institutes for BioMedical Research) ;
Cameron, Scott (Novartis Institutes for BioMedical Research) ;
Varga, Andreea (Gustave Roussy Cancer Campus) ;
Taylor, Matthew (Oregon Health & Science University) ;
Universitat Autònoma de Barcelona
visitant ::
identificació
Subscriure's to this discussion. You will then receive all new comments by email.
